Zhaoke Ophthalmology Limited
HKEX:6622.HK
1.38 (HKD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 1,461.623 | 1,716.351 | 2,128.429 | 65.096 | 154.769 | 7.217 |
| Short Term Investments
| 0 | 8.873 | 8.157 | 806.247 | 83.721 | 0 |
| Cash and Short Term Investments
| 1,461.623 | 1,725.224 | 2,136.586 | 871.343 | 238.49 | 7.217 |
| Net Receivables
| 3.71 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 6.141 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 323.095 | 247.523 | 72.308 | 42.28 | 141.117 | 8.079 |
| Total Current Assets
| 1,794.569 | 1,972.747 | 2,208.894 | 913.623 | 379.607 | 15.296 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 233.306 | 263.253 | 234.13 | 174.272 | 137.706 | 121.668 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 392.463 | 334.623 | 162.383 | 138.691 | 36.901 | 38.945 |
| Goodwill and Intangible Assets
| 392.463 | 334.623 | 162.383 | 138.691 | 36.901 | 38.945 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0 | 0 | 0 | 0 | 0 | 0.357 |
| Total Non-Current Assets
| 625.769 | 597.876 | 396.513 | 312.963 | 174.607 | 160.97 |
| Total Assets
| 2,420.338 | 2,570.623 | 2,605.407 | 1,226.586 | 554.214 | 176.266 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 11.74 | 0 | 0 | 0 | 0 | 181.917 |
| Short Term Debt
| 216.162 | 104.225 | 16.171 | 14.749 | 4.702 | 3.427 |
| Tax Payables
| 1.602 | 1.203 | 5.529 | 4.92 | 0.039 | 0 |
| Deferred Revenue
| 0 | -11.051 | -14.685 | -0.996 | -163.54 | 0 |
| Other Current Liabilities
| 106.947 | 89.112 | 67.308 | 33.997 | 179.093 | 8.282 |
| Total Current Liabilities
| 336.451 | 194.54 | 89.008 | 53.666 | 183.834 | 193.626 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 21.864 | 27.703 | 20.861 | 22.778 | 26.089 | 22.677 |
| Deferred Revenue Non-Current
| 13.705 | 0.007 | 0.051 | 0.094 | 0.138 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | -0.007 | -0.051 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 1,896.11 | 369.823 | 0.181 |
| Total Non-Current Liabilities
| 35.569 | 27.71 | 20.912 | 1,918.888 | 395.912 | 22.858 |
| Total Liabilities
| 372.02 | 222.25 | 109.92 | 1,972.554 | 579.746 | 216.484 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings
| -3,806.856 | -3,429.275 | -3,021.958 | -892.178 | -165.197 | -43.12 |
| Accumulated Other Comprehensive Income/Loss
| 411.538 | 350.137 | 103.481 | 82.081 | 7.435 | 2.902 |
| Other Total Stockholders Equity
| 5,443.636 | 5,427.511 | 5,413.964 | 146.21 | 139.665 | 0 |
| Total Shareholders Equity
| 2,048.318 | 2,348.373 | 2,495.487 | -745.968 | -25.532 | -40.218 |
| Total Equity
| 2,048.318 | 2,348.373 | 2,495.487 | -745.968 | -25.532 | -40.218 |
| Total Liabilities & Shareholders Equity
| 2,420.338 | 2,570.623 | 2,605.407 | 1,226.586 | 554.214 | 176.266 |